80 related articles for article (PubMed ID: 21892915)
1. MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice.
Case SR; Martin RJ; Jiang D; Minor MN; Chu HW
Exp Lung Res; 2011 Oct; 37(8):500-8. PubMed ID: 21892915
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance.
Wu Q; Martin RJ; Lafasto S; Efaw BJ; Rino JG; Harbeck RJ; Chu HW
Am J Respir Crit Care Med; 2008 Apr; 177(7):720-9. PubMed ID: 18202345
[TBL] [Abstract][Full Text] [Related]
3. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation.
Kumar M; Ahmad T; Sharma A; Mabalirajan U; Kulshreshtha A; Agrawal A; Ghosh B
J Allergy Clin Immunol; 2011 Nov; 128(5):1077-85.e1-10. PubMed ID: 21616524
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
Sharkhuu T; Matthaei KI; Forbes E; Mahalingam S; Hogan SP; Hansbro PM; Foster PS
Clin Exp Allergy; 2006 Dec; 36(12):1575-83. PubMed ID: 17177681
[TBL] [Abstract][Full Text] [Related]
5. TLR 5, but neither TLR2 nor TLR4, is involved in lung epithelial cell response to Burkholderia cenocepacia.
de C Ventura GM; Le Goffic R; Balloy V; Plotkowski MC; Chignard M; Si-Tahar M
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):37-44. PubMed ID: 18680520
[TBL] [Abstract][Full Text] [Related]
6. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells.
Bérubé J; Bourdon C; Yao Y; Rousseau S
Cell Signal; 2009 Mar; 21(3):448-56. PubMed ID: 19121387
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
[TBL] [Abstract][Full Text] [Related]
8. TLR 2 and CD14 mediate innate immunity and lung inflammation to staphylococcal Panton-Valentine leukocidin in vivo.
Zivkovic A; Sharif O; Stich K; Doninger B; Biaggio M; Colinge J; Bilban M; Mesteri I; Hazemi P; Lemmens-Gruber R; Knapp S
J Immunol; 2011 Feb; 186(3):1608-17. PubMed ID: 21178007
[TBL] [Abstract][Full Text] [Related]
9. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression.
Oglesby IK; Bray IM; Chotirmall SH; Stallings RL; O'Neill SJ; McElvaney NG; Greene CM
J Immunol; 2010 Feb; 184(4):1702-9. PubMed ID: 20083669
[TBL] [Abstract][Full Text] [Related]
10. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection.
Loures FV; Pina A; Felonato M; Calich VL
J Immunol; 2009 Jul; 183(2):1279-90. PubMed ID: 19553529
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury.
Mersmann J; Berkels R; Zacharowski P; Tran N; Koch A; Iekushi K; Dimmeler S; Granja TF; Boehm O; Claycomb WC; Zacharowski K
Crit Care Med; 2010 Mar; 38(3):903-9. PubMed ID: 20081527
[TBL] [Abstract][Full Text] [Related]
12. Allergic sensitization is enhanced in early life through toll-like receptor 7 activation.
Phipps S; Hansbro N; Lam CE; Foo SY; Matthaei KI; Foster PS
Clin Exp Allergy; 2009 Dec; 39(12):1920-8. PubMed ID: 19735273
[TBL] [Abstract][Full Text] [Related]
13. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation.
Takahashi K; Hirose K; Kawashima S; Niwa Y; Wakashin H; Iwata A; Tokoyoda K; Renauld JC; Iwamoto I; Nakayama T; Nakajima H
J Allergy Clin Immunol; 2011 Nov; 128(5):1067-76.e1-6. PubMed ID: 21794904
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
15. A new mechanism regulating the initiation of allergic airway inflammation.
Kiss A; Montes M; Susarla S; Jaensson EA; Drouin SM; Wetsel RA; Yao Z; Martin R; Hamzeh N; Adelagun R; Amar S; Kheradmand F; Corry DB
J Allergy Clin Immunol; 2007 Aug; 120(2):334-42. PubMed ID: 17544098
[TBL] [Abstract][Full Text] [Related]
16. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
[TBL] [Abstract][Full Text] [Related]
17. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Biochem Biophys Res Commun; 2006 Jan; 339(4):1048-55. PubMed ID: 16337148
[TBL] [Abstract][Full Text] [Related]
18. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
[TBL] [Abstract][Full Text] [Related]
19. Bacterial superantigens enhance the in vitro proinflammatory response and in vivo lethality of the TLR2 agonist bacterial lipoprotein.
Kearney DE; Wang W; Redmond HP; Wang JH
J Immunol; 2011 Nov; 187(10):5363-9. PubMed ID: 22003201
[TBL] [Abstract][Full Text] [Related]
20. Local treatment with BPPcysMPEG reduces allergic airway inflammation in sensitized mice.
Knothe S; Mutschler V; Rochlitzer S; Winkler C; Ebensen T; Guzman CA; Hohlfeld J; Braun A; Muller M
Immunobiology; 2011; 216(1-2):110-7. PubMed ID: 20619481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
